MDT Quote, Financials, Valuation and Earnings

Boston Scientific Corp. has a net margin of 12.75% compared to Medtronic Plc's net margin of 12.68%. Medtronic Plc's return on equity of 9.84% beat Boston Scientific Corp.'s return on equity of 12.55%.

Medtronic Plc has a consensus price target of $111.77, signalling upside risk potential of 14.54%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.75 which suggests that it could grow by 38.34%. Given that Boston Scientific Corp. has higher upside potential than Medtronic Plc, analysts believe Boston Scientific Corp. is more attractive than Medtronic Plc.

Medtronic Plc has a beta of 0.709, which suggesting that the stock is 29.108% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.441%.

Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 2.9%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend. Medtronic Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic Plc quarterly revenues are $9B, which are larger than Boston Scientific Corp. quarterly revenues of $5.3B. Medtronic Plc's net income of $1.2B is higher than Boston Scientific Corp.'s net income of $670M. Notably, Medtronic Plc's price-to-earnings ratio is 27.21x while Boston Scientific Corp.'s PE ratio is 39.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.54x versus 5.64x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Globus Medical, Inc. has a net margin of 12.75% compared to Medtronic Plc's net margin of 15.47%. Medtronic Plc's return on equity of 9.84% beat Globus Medical, Inc.'s return on equity of 10.08%.

Medtronic Plc has a consensus price target of $111.77, signalling upside risk potential of 14.54%. On the other hand Globus Medical, Inc. has an analysts' consensus of $107.17 which suggests that it could grow by 17.87%. Given that Globus Medical, Inc. has higher upside potential than Medtronic Plc, analysts believe Globus Medical, Inc. is more attractive than Medtronic Plc.

Medtronic Plc has a beta of 0.709, which suggesting that the stock is 29.108% less volatile than S&P 500. In comparison Globus Medical, Inc. has a beta of 1.056, suggesting its more volatile than the S&P 500 by 5.621%.

Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 2.9%. Globus Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Globus Medical, Inc. pays out -- of its earnings as a dividend. Medtronic Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic Plc quarterly revenues are $9B, which are larger than Globus Medical, Inc. quarterly revenues of $769M. Medtronic Plc's net income of $1.2B is higher than Globus Medical, Inc.'s net income of $119M. Notably, Medtronic Plc's price-to-earnings ratio is 27.21x while Globus Medical, Inc.'s PE ratio is 29.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.54x versus 4.52x for Globus Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Intuitive Surgical, Inc. has a net margin of 12.75% compared to Medtronic Plc's net margin of 27.89%. Medtronic Plc's return on equity of 9.84% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.

Medtronic Plc has a consensus price target of $111.77, signalling upside risk potential of 14.54%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $611.82 which suggests that it could grow by 22.48%. Given that Intuitive Surgical, Inc. has higher upside potential than Medtronic Plc, analysts believe Intuitive Surgical, Inc. is more attractive than Medtronic Plc.

Medtronic Plc has a beta of 0.709, which suggesting that the stock is 29.108% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.653, suggesting its more volatile than the S&P 500 by 65.303%.

Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 2.9%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend. Medtronic Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic Plc quarterly revenues are $9B, which are larger than Intuitive Surgical, Inc. quarterly revenues of $2.9B. Medtronic Plc's net income of $1.2B is higher than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, Medtronic Plc's price-to-earnings ratio is 27.21x while Intuitive Surgical, Inc.'s PE ratio is 63.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.54x versus 18.00x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Stryker Corp. has a net margin of 12.75% compared to Medtronic Plc's net margin of 11.84%. Medtronic Plc's return on equity of 9.84% beat Stryker Corp.'s return on equity of 15.17%.

Medtronic Plc has a consensus price target of $111.77, signalling upside risk potential of 14.54%. On the other hand Stryker Corp. has an analysts' consensus of $424.40 which suggests that it could grow by 13.88%. Given that Medtronic Plc has higher upside potential than Stryker Corp., analysts believe Medtronic Plc is more attractive than Stryker Corp..

Medtronic Plc has a beta of 0.709, which suggesting that the stock is 29.108% less volatile than S&P 500. In comparison Stryker Corp. has a beta of 0.873, suggesting its less volatile than the S&P 500 by 12.679%.

Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 2.9%. Stryker Corp. offers a yield of 0.91% to investors and pays a quarterly dividend of $0.88 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Stryker Corp. pays out 40.48% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Medtronic Plc quarterly revenues are $9B, which are larger than Stryker Corp. quarterly revenues of $7.2B. Medtronic Plc's net income of $1.2B is higher than Stryker Corp.'s net income of $849M. Notably, Medtronic Plc's price-to-earnings ratio is 27.21x while Stryker Corp.'s PE ratio is 44.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.54x versus 5.73x for Stryker Corp.. Usually stocks with elevated PS ratios are considered overvalued.